Method of using octahydro pyrazolo[3,4-g]quinolines
Patent 4367231 Issued on January 4, 1983. Estimated Expiration Date: 
March 20, 2000. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
March 20, 2000. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3084165 3600393 3859291 InventorsAssigneeApplicationNo. 06/132360 filed on 03/20/1980US Classes:514/293, Three or more hetero atoms in the tricyclo ring system546/157, Chalcogen attached directly at 2-position by nonionic bonding546/164, Fully saturated quinolines546/165, Single bond between 1,2-positions and single bond between 3,4-positions546/166, The six-membered hetero ring is unsubstituted or alkyl substituted only546/82Three or more ring hetero atoms in the tricyclo ring systemExaminersPrimary: Daus, Donald G.Assistant: Turnipseed, James H. Attorney, Agent or FirmInternational ClassesC07D 491/04 (20060101)C07D 491/00 (20060101) C07D 215/00 (20060101) C07D 215/20 (20060101) C07D 215/227 (20060101) AbstractMethod of treating Parkinson's Syndrome by administering a tautomeric mixture of a 5-(C1 -C3)alkyl or allyl-7-permissibly substituted-4,4a,5,6,7,8,8a,9-octahydro-1H-pyrazolo[3,4-g]quinolines.Other References
|
| ||||||||||||||
